The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes

The International Journal of Developmental Biology
Adriana AlbiniClaudio Brigati

Abstract

Several genetic and epigenetic factors, both in the cell and in the host, contribute to the progression of tumors towards metastases. The escape of cancer cells from a primary, localized tumor to distant organs transforms a relatively curable pathology to an almost untreatable one. Metastatic lesions are often resistant to cancer therapy because of the progressive phenotypic changes that they have undergone. In this article we will give a bird's eye view on the features of metastatic cells and potential therapeutic targets. In particular, the invasion of basement membranes represents a fundamental step for cell dispersion. Over seventeen years ago we established the Matrigel "chemoinvasion" assay, a useful tool for studying the mechanisms involved in tumor and endothelial cell invasion of basement membranes and for the screening of anti-invasive agents. We will describe the assay and review some of the major results it enabled to obtain.

Citations

Jan 12, 2008·Clinical & Experimental Metastasis·Patrick Subarsky, Richard P Hill
Apr 18, 2013·Human Molecular Genetics·Urszula OleksiewiczGeorge Xinarianos
Aug 25, 2006·Cancer Cell International·Inder SehgalJoseph Francis
Mar 15, 2006·Neuro-oncology·Tiziana PiepoliGaetano Finocchiaro
Jul 17, 2008·Biological Chemistry·Rebecca S HenkhausNatalia A Ignatenko
Jul 29, 2010·International Journal of Oncology·Behjatolah Monzavi-KarbassiThomas Kieber-Emmons
Apr 21, 2012·Future Oncology·Christina E StevensonKazuaki Takabe
Jul 24, 2010·Journal of Oncology·Christina ColemanDavid A Goukassian
Apr 3, 2007·Neoplasia : an International Journal for Oncology Research·Ellen AckerstaffZaver M Bhujwalla
Mar 1, 2016·Bioscience, Biotechnology, and Biochemistry·Seo Ho KimTack-Joong Kim
Aug 1, 2009·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jean-François MayolDidier Wion
Jun 6, 2009·Journal of Cellular Physiology·G BentonI P Arnaoutova
Jul 1, 2009·International Journal of Experimental Pathology·Carolyn A StatonNicola J Brown
Dec 7, 2007·British Journal of Pharmacology·M G CattaneoL M Vicentini
Jun 29, 2005·Seminars in Cancer Biology·Ruoxiang WangLeland W K Chung
Feb 21, 2006·FEMS Microbiology Letters·Stephen P SavilleJosé L López Ribot
Jan 29, 2010·PLoS Pathogens·Palanivel VelupillaiThomas Benjamin
Oct 25, 2016·Biochimica Et Biophysica Acta·Otília MenyhártBalázs Győrffy
Feb 22, 2017·Biochimica Et Biophysica Acta. General Subjects·Xiaojie WuChristy L Haynes
Apr 12, 2011·Journal of Cutaneous Medicine and Surgery·Wency IpYouwen Zhou
Dec 1, 2017·Integrative Biology : Quantitative Biosciences From Nano to Macro·N PeelaM Nikkhah
Feb 24, 2011·International Journal of Cancer. Journal International Du Cancer·Gabriel BentonIrina Arnaoutova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.